Citation tools
"64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry." Journal of Nuclear Medicine
64.5
(2023):
704-710.
Web. 07 May. 2025.